baber/WOPTO huggingface dataset:
Patent NZ-192573-A (NZ)
Title: Catalyst component and olefine polymerisation catalyst containing the component
Inventor: GAVENS P
IPC: C08F10/00
Filed: 1980-01-10
Abstract: A component of a polymerisation catalyst is prepared by reacting an organo-magnesium compound, or a complex with an organo-aluminium compound, with an halogenating agent such as silicon tetrachloride or hydrogen chloride, and then reacting the product with a Lewis Base compound, particularly an ester and finally with titanium tetrachloride. The product obtained is combined with an organo-aluminium compound preferably together with a Lewis Base and used to polymerise an olefine monomer particularly propylene. The catalyst system has a high activity and is stereospecific.
Patent NZ-196995-A (NZ)
Title: Continuously thermoforming sheet of thermoplastic material
Inventor: KEITH D G
IPC: B29C51/08
Filed: 1981-05-04
Abstract: 1. Process for formation of a number of hollow profiles joined to one another at the base (22) on a continuous length (16) of material with thermoplastic softening behaviour, whereby the material is exposed to pin-shaped forming tools (12, 12') located vertically in relation to the material plane, employing a device (2) for heating up the material to a temperature of sufficient plasticizability, using top and/or bottom driver devices (7', 7", 9, 11) located in a circle by drive elements for a number of interchangeable box or plate-shaped support elements (6, 6') matched to the material width, gripped and moved at both ends by the driver devices via support and roller elements fitted at the ends and underneath, for location of a number of pin-shaped forming tools (12, 12'), characterized by the fact that the support elements (6, 6') have cylindrical stub-shaped pivots, dogs or studs (7, 25, 26, 27, 28) projecting on both sides, with which engage rod-shaped driver elements (9) moved about vertical axes of rotation (for the purpose of parallel alignment of the support elements (6, 6') which under pressure operate in opposition to one another or approach one another vertically and horizontally), which are used for horizontal advance of the support elements (6, 6') until they engage with a driver rim (11), by means of which the support elements (6, 6') are moved into operating position at the material infeed (D) by change of direction, employing several spindles (10) to adjust the depth of penetration of the forming tools, particularly in the region of the material infeed and take-off zones (D, C), whereby the speeds of the drive elements for the return devices (7', 7"), the rod-shaped driver elements (9) and the driver rims (11), as well as for the continuously operating spindles (10) are regulated and matched to one another.
Patent NZ-218041-A (NZ)
Title: Composition containing a penem or a carbapenem antibiotic and an n-acylated derivative of an amino acid
Inventor: TAKASHI SHIOKARI
IPC: A61K31/40
Filed: 1986-10-23
Abstract: Administration of an N-acylated amino acid in association with a penem or carbapenem antibiotic relieves or eliminates the renal problems associated with administration of the antibiotic alone. The amino acid derivative and antibiotic may be formulated together as a composition or administered separately, either simultaneously or sequentially. The composition may be prepared by simple mixing.
Patent NZ-222091-A (NZ)
Title: Portable hinged distribution rack
Inventor: ANDERSSON K
IPC: A47F5/13
Filed: 1987-10-08
Abstract: A distribution system comprising box-shaped transport containers (5) provided with bottom (18) and walls (20) and a truck (1) provided with wheels which has swinging side walls (3 and 4) in hinged connection with a vertical end wall (2). The side walls (3 and 4) have supporting elements placed oppositely in pairs, e.g. horizontal L-shaped rails (22) which are positively engageable with members formed on the transport trays (5), e.g.channels (21) incorporated at the bottom (18) of the transport trays, to facilitate in co-operation with these members loading by insertion of the transport trays (5) and securing of the side walls (3 and4) when these are in their active position.
Patent NZ-232126-A (NZ)
Title: Back support with buckle to connect the leg straps together
Inventor: TOSO VICTOR
IPC: A47C16/00
Filed: 1990-01-16
Abstract: A back support (10) adapted to engage the lumbar region of the wearer having a pair of straps (16, 18) which extend longitudinally from the ends (20, 22) of the support member (12) and terminate in loops to engage the knees of the wearer when the wearer is seated on the ground or on a backless support, such as a bench or the like. The force of the wearer's knees on the straps (16, 18) pulls the back-supporting member (12) against the lower back supporting it and enabling the wearer to sit upright comfortably for extended periods of time. The back support (10) is provided with an integrally formed container pack by providing a closure member (14) along the outside periphery of the support (12) which, in the closed position, forms a container pack for the straps (16, 18). Carrying handles (28, 29) are provided. The back support (10) further includes a buckle (30) for connecting the straps (16, 18) together thereby restricting movement of the legs away from each other. The back support (10) also includes a retainer strap (40) to attach and maintain the back support (10) in position on the back of the user when the straps (16, 18) are disengaged from the knees of the user.
Patent NZ-232568-A (NZ)
Title: O-(1,2,4-triazol-1-yl) o-phenyl acetals and fungicidal compositions
Inventor: BAUS ULF
IPC: C07D521/00
Filed: 1990-02-16
Abstract: Compounds of the general formula   <IMAGE> I  where 5 R is alkyl or substituted or unsubstituted aryl, X is C=O or CHOH and derivatives thereof, Y is hydrogen, alkyl, alkoxy, halogen, aryl or aryloxy, and n is 1 to 5, and fungicides containing these compounds.
Patent NZ-235142-A (NZ)
Title: Catheter probe sensor assembly.
Inventor: METZGER MARK G
IPC: A61M25/00
Filed: 1990-09-03
Abstract: A catheter sensor assembly comprises:   a) an elongate member (11) with a distal end (12) to ease insertion of the catheter sensor assembly (16) and a proximal extension (13) shaped for fitment of the member into a lumen (20) of a catheter tube (30), the distal end (12) and the proximal extension (13) joined by an intermediate part (14); b) a lower section (36) having a curved bottom (37) defining the tubular shape of the elongate member (11) so that when the proximal extension (13) is fit within the lumen (20) the tubular member extends distally therefrom; c) a passage (15) opened in a first direction and extending along the proximal extension and across the intermediate part; d) a sensor (16) carried upon and overlying the passage intermediate part near the distal end, the sensor having a bottom surface (17) of substantially planar configuration and a top (18) with an open recess (38) so that the top recess faces in the first direction when the sensor covers the passage with the bottom planar surface in communication with a distal portion of the passage and the lumen (20); e) conductors (25) attached to an area of the sensor bottom planar surface near the proximal extension for transmitting signals from the sensor (16) through the lumen; and f) an adhesive sealant (27, 28) between the sensor and the intermediate part about the bottom planar surface for securing the sensor to the member on the intermediate part near the distal end with the sealant also across the conductors and the area of the sensor that the sealant does not close the entire passage. (
Patent NZ-238111-A (NZ)
Title: Preparing a concentrate of coagulation factors from blood
Inventor: WEIS-FOGH ULLA
IPC: A61K35/16
Filed: 1991-05-10
Abstract: An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample, comprises a first chamber (14) for collection and separation of said blood sample so as to separate a plasma fraction, and a second chamber (15) for collection of said plasma fraction through a tubing member (22, 30) and a valve (24) and for precipitation of said concentrate. The apparatus comprises furthermore a .removable syringe (36) for receiving the concentrate from the second chamber (15) through a tubing member (32). The first and the second chamber (14, 15) are partially defined by the same integrally formed solid container wall (2) and comprise a common partition. The first chamber (14) is further defined by a piston (4) displaceable both in connection with the blood sample collection and the transfer of said plasma fraction to the second chamber (15) and in connection with returning said plasma fraction to the first chamber (14) upon the precipitation of the concentrate.
Patent NZ-238753-A (NZ)
Title: Separating a tea extract into two aqueous phases.
Inventor: DYKS ANDREW JAMES
IPC: A23F3/16
Filed: 1991-06-27
Abstract: Tea extract is separated into a lighter coloured and a darker coloured phase by changing the natural self-separating capacity of the tea extract by concentrating the extract to 6-45 wt%, preferably 12-30 wt% solids, cooling the concentrate below 5 DEG C and isolating the separated phases. The lighter coloured phase is used in preparing clear cold-water soluble tea, reduced caffeine tea, isotonic tea. The darker coloured phase may be used to prepare hot-water soluble instant tea, colouring agent, antioxidant or tea flavouring agent.
Patent NZ-240956-A (NZ)
Title: Memory card with speech generator
Inventor: BIJL JACOBUS CORNELIS
IPC: G10L13/04
Filed: 1991-12-12
Abstract: A memory card (1) with a data memory containing data for user information includes a speech generator (2). In the data memory or in a separate, integrated text memory (3), a memory-card-specific vocabulary is stored in the form of a program (software). The speech generator (2) is controlled in accordance with the software via an external control unit associated with an input device for the memory card (1). At an output line (9), corresponding analog speech signals are then available in the form of user information, particularly an input acknowledgement or user guidance. If the memory card is used in a programmable switching system, service-feature-specific user information can be outputted in the language of the user. The conventional central text storage is no longer necessary. <IMAGE>
Patent NZ-242593-A (NZ)
Title: Amino acids or dipeptides containing a c-terminal 2-(carboxy or carboxamido) cycloalkyl substituent and pharmaceutical compositions
Inventor: MARTIN JOSEPH ARMSTRONG
IPC: C07D263/06
Filed: 1992-05-04
Abstract: Compounds of the formula <CHEM> wherein R<1> represents alkoxycarbonyl, aralkoxycarbonyl, alkanoyl, aralkanoyl, heterocyclylcarbonyl or a group of the formula <CHEM> R<2> represents alkyl, cycloalkylalkyl or aralkyl; R<3> represents hydrogen and R<4> represents hydroxy or R<3> and R<4> together represent oxo; R<5> represents alkoxycarbonyl or alkylcarbamoyl; R<6> and R<7> together represent trimethylene or tetramethylene optionally substituted by alkyl or on adjacent carbon atoms by tetramethylene; R<8> represents alkoxycarbonyl, aralkoxycarbonyl, alkanoyl, aroyl, aralkanoyl or heterocyclylcarbonyl; and R<9> represents alkyl, cycloalkyl, cycloalkylalkyl, aralkyl, cyanoalkyl, carbamoylalkyl, alkylthioalkyl, alkoxyalkyl or alkoxycarbonylalkyl, and pharmaceutically acceptable acid addition salts of those compounds of formula I which are basic, inhibit aspartyl proteases of viral origin and can be used in the form of medicaments for the prophylaxis or treatment of viral infections. They can be manufactured according to generally known methods.
Patent NZ-248398-A (NZ)
Title: Inhaler: powder filled cups of metering member moved to inhalation passage
Inventor: BRAITHWAITE PHILIP WILSON
IPC: A61M15/00
Filed: 1991-07-12
Abstract: The invention provides an inhaler for delivering a substance in a finely divided form from a storage chamber within the inhaler. The inhaler comprises a metering member operable to transfer a dose of the substance from the storage chamber (10) to an inhalation passage (15), the metering member having a frusto-conical metering surface (7) which is indented to provide at least one dispensing cup (8) and being moveable between a first position in which a dispensing cup (8) is presented to the storage chamber (10) to receive a dose of the substance and a second position in which a dose of the substance is presented to the inhalation passage (15) in an upwardly open dispensing cup (8). The body (4) of the inhaler comprises a seat having an annular, frusto-conical contact surface making sliding contact with the metering surface and defining a socket within which the metering member (6) is journalled for rotation between its first and second positions. The use of a frusto-conical metering member allows a good seal to be obtained between it and the seat and also makes the inhaler relatively compact. <IMAGE>
Patent NZ-254945-A (NZ)
Title: Inhalation powder containing an antistatic agent in the carrier
Inventor: SIMPKIN GORDON THOMAS
IPC: A61K45/08
Filed: 1993-08-13
Abstract: A powder composition for inhalation comprising at least one microfine drug and a carrier, in which at least a portion of the said carrier comprises an antistatic agent.
Patent NZ-260159-A (NZ)
Title: N-bicyclic nitrogen compounds and medicaments
Inventor: DE NANTEUIL GUILLAUME
IPC: A61P25/26
Filed: 1994-03-23
Abstract: The invention relates to the compounds of formula (I): <IMAGE>  in which:   A represents, with the carbon and nitrogen atoms to which it is attached, a heterocycle, B represents, with the nitrogen atom to which it is attached, a heterocycle,   n is equal to 1, 2, 3 or 4, R represents a phenyl group substituted by at least one halogen atom or one alkyl, hydroxyl, alkoxy, trifluoromethyl, nitro, amino, cyano, carboxyl or alkoxycarbonyl group, a benzyl group, a thienyl group or a pyridyl group.   Medicaments.
Patent NZ-269826-A (NZ)
Title: Bicyclo(2.2.2)octane derivatives; compounds, preparation and pharmaceutical compositions
Inventor: KALINDJIAN SARKIS BARRET
IPC: A61K31/404
Filed: 1994-08-09
Abstract: Compounds of formula (I) wherein R<1> and R<2> are independently H, methyl, halo, carboxy, esterified carboxy, amidated carboxy, carboxymethyl, esterified carboxymethyl or amidated carboxymethyl; R<3> and R<4> (or each R<3> and R<4> group, when m or n is 2 or more) are independently selected from halo, amino, nitro, cyano, sulphamoyl, sulphonyl, trifluoromethyl, C1 to C3 alkyl, C1 to C3 alkoxy, hydroxy, C1 to C3 hydroxyalkyl, C1 to C3 alkylcarboxyamino, carboxy, esterified carboxy and amidated carboxy; R<5> and R<6> are independently selected from H and the groups recited above for R<3>; m is from 0 to 4, provided that m is not more than 2 unless R<3> is exclusively halo; n is from 0 to 4, provided that n is not more than 2 unless R<4> is exclusively halo; R<7>, R<9> and R<10> are independently H or C1 to C3 alkyl; R<8> is H or C1 to C15 hydrocarbyl, in which one or more hydrogen atoms of the hydrocarbyl group may be replaced by a halogen atom, and up to two of the carbon atoms may be replaced by a nitrogen, oxygen or sulphur atom, provided that R<8> does not contain a -O-O-group; U is aryl, substituted aryl, heterocyclic, substituted heterocyclic or cycloalkyl, and Z is a group of formula (II) or (III) (wherein R is H or C1 to C3 alkyl; X is -CO2H or tetrazolyl; Y is H, -CO2H, tetrazolyl, -CH2OH, -CO2Me or -CONH2, and a is from 0 to 2); and pharmaceutically acceptable salts thereof have a high affinity for CCK and/or gastrin receptors.
Patent NZ-289552-A (NZ)
Title: Separating emulsified organic soil from aqueous effluent using emulsion destabilizer
Inventor: FALBAUM DAVID J
IPC: C09K23/18
Filed: 1995-06-08
Abstract: Improved separation of emulsified hydrophobic organic soils can be obtained from aqueous effluents using an amphoteric carboxylate surfactant material in combination with cationic destabilizer or flocculent materials. Such a treatment in combination with an acidic pH adjustment causes the rapid separation of hydrophobic organic soils from the aqueous stream. The treated aqueous stream is environmentally compatible. Improved laundry detergents comprising an organic amphoteric carboxylate surfactant and selected nonionic surfactants provide both cleaning for fiber and fabric containing items soiled with substantial quantities of hydrophobic soil. The pH of an effluent generated in such cleaning processes can be adjusted to an acid pH and treated with a cationic material causing a break that permits rapid and substantially complete separation of the hydrophobic organic soils from the effluent. Residual concentrations of organic soil in effluent water can be less than 250 ppm and can be as low as 10 ppm.
Patent NZ-310391-A (NZ)
Title: Polypeptides that stimulate bone growth
Inventor: TAM CHERK SHING
IPC: C07K14/51
Filed: 1996-06-07
Abstract: Polypeptides which stimulate bone growth are described based on the sequences: (a) Gly Ile Gly Lys Arg Thr Asn Glu His Thr Ala Asp Cys Lys Ile Lys Pro Asn Thr Leu His Lys Lys Ala Ala Glu Thr Leu Met Val; (b) Gly Ile Gly Lys Arg Thr Asn Glu His Thr Ala Asp Cys Lys Ile Lys Pro Asn Thr Leu His Lys Lys Ala Ala; (c) Gly Ile Gly Lys Arg Thr Asn Glu His Thr Ala Asp Cys Lys Ile Lys Pro Asn Thr Leu; and (d) Gly Ile Gly Lys Arg Thr Asn Glu His Thr Ala Asp Cys Lys Ile. The associated nucleotide sequences, methods of preparation and use, and antibodies and kits based upon them are described, as well
Patent NZ-315609-A (NZ)
Title: 8-N-Anthrazalone derivatives
Inventor: CARUSO MICHELE
IPC: A61P25/28
Filed: 1996-07-23
Abstract: The present invention relates to  aza-anthracyclinone derivatives of the formula wherein  X1 and X2 are C=O, C=NH or CH2, X3 is CH2, CO, CHOH, formula (III), formula (IV) wherein n=2 or 3, and C=N(R9) wherein R9 is hydroxy or amino-aryl, and each of R1, R2, R3, R4, R5, R6, R7 and R8 are hydrogen, halogen or an organic residue, are useful in the treatment of amyloidosis. A process for their preparation and pharmaceutical compositions containing them are also described.
Patent NZ-321430-A (NZ)
Title: A transfer resistant lipstick composition containing an organosiloxane resin a diorganopolysiloxane polymer and a carrier
Inventor: DRECHSLER LEE ELLEN
IPC: A61K8/97
Filed: 1996-10-25
Abstract: The present invention is for cosmetic compositions applied to the lips providing significant benefits to the user. These compositions comprise the combination of organosiloxane resins and fluid diorganosiloxane resins with a volatile carrier.
Patent NZ-326897-A (NZ)
Title: 5 <alpha>-reductase inhibitory preparation for oral administration, process for producing the same, and use thereof
Inventor: USUI FUSAO
IPC: A61K9/20
Filed: 1997-02-04
Abstract: Providing a formulation of a 5 alpha -reductase inhibitor for oral administration. ÄMeans for SolutionÜ   A formulation of a 5 alpha -reductase inhibitor for oral administration, which comprises a composition obtained by grinding a mixture of an azasteroid, a water-soluble polymer and a disintegrant.
Patent NZ-328475-A (NZ)
Title: A pharmaceutical composition containing a polypeptide up to 40 kD and an enhancer for systemic delivery by inhalation
Inventor: BAECKSTROEM KJELL GOERAN ERIK
IPC: A61K38/02
Filed: 1994-06-24
Abstract: Pharmaceutical compositions containing a mixture of a pharmaceutically active polypeptide and an enhancer compound which enhances the systemic absorption of the polypeptide in the lung of a patient.  The mixture is administered by inhalation in the form of a dry powder, in which at least 50 % of the total mass of polypeptide and enhancer consists of primary particles having a diameter less than or equal to about 10 microns, the primary particles optionally being formed into agglomerates. The polypeptide may be any medically or diagnostically useful peptide or protein of small to medium size, i.e. up to about 40 kD molecular weight (MW), for which systemic delivery is desired. The enhancer compound can be any compound which enhances the absorption of the polypeptide through the epithelium of the lower respiratory tract, and into the systemic circulation.
Patent NZ-334183-A (NZ)
Title: Capacitive reusable electrosurgical return electrode
Inventor: FLEENOR RICHARD P
IPC: A61B18/16
Filed: 1997-10-14
Abstract: A reusable electrosurgical return electrode pad for use with electrosurgery. In one embodiment it includes a presentation or working surface area lying in the range of from about 11 to about 1,500 square inches. In another the working surface is at least as large as that of a projection of about half of the profile of the trunk of a patient. In yet another, it includes a working surface area at least as large as that of a projection of the profile of both the trunk and legs of a patient. It is adapted for disposition on the working surface of an operating table or dentist's chair immediately underlying a patient during electrosurgery. By presenting a very large surface area, the need for direct contact or contact through conducting jells is eliminated; through employment of washable surface areas, it is made readily cleanable and reusable; and through the inclusion of capacitive. coupling and selection of impedance characteristics for the materials and geometries, it is made self-limiting as to current density and temperature rise so as to prevent patient trauma. An optional sleeve is provided for cooperative use with the electrode.
Patent NZ-334350-A (NZ)
Title: 3-substituted pyrido[4',3':4,5]thieno[2,3-d]pyrimidine derivatives and treatment of depression
Inventor: STEINER GERD
IPC: C07D495/14
Filed: 1997-08-22
Abstract: In the compounds of formula I: R1 is a hydrogen atom, a C1-C4 alkyl group, an acetyl or benzoyl group, a phenylalkyl C1-C4 radical (the aromatic optionally being substituted by halogen, C1-C4 alkyl, trifluoromethyl, hydroxy, C1-C4 alkoxy, amino, cyano or nitro groups), a naphthylalkyl C1-C3 group, a phenylalkanone C2-C3 radical or a phenylcarbamoylalkyl C2 radicalgroup (wherein the phenyl group can be substituted by halogen). R2 is a phenyl, pyridyl, pyrimidinyl or pyrazinyl group, each of which can optionally be mono-di- or tri-substituted by halogen atoms, C1-C4 alkyl, trifluoromethyl, trifluoromethoxy, hydroxyl, C1-C4 alkoxy, amino, monomethylamino, dimethylamino, cyano or nitro groups, and each of these may be fused to a benzene nucleus optionally mono- or di-substituted by halogen atoms, C1-C4 alkyl, hydroxyl, trifluoromethyl, C1-C4 alkoxy, amino, cyano or nitro groups, and optionally containing 1 nitrogen atom, or a 5- or 6-member ring which can contain between 1 and 2 oxygen atoms or be substituted by a phenyl-C1-C2 alkyl or alkoxy group, wherein the phenyl group can be substituted by halogen, a methyl, trifluoromethyl or methoxy group; A is NH or an oxygen atom; B is hydrogen or methyl; C is hydrogen, methyl or hydroxyl; X is a nitrogen atom; Y is CH2, CH2-CH2, CH2-CH2-CH2 or CH2-CH; Z is a nitrogen atom, a carbon atom or CH, wherein the bond between Y and Z can also be a double bond; and n is the number 2, 3 or 4. These compounds are suitable as medicaments for treating diseases in which the serotonin concentration is reduced and in which the activity of the presynaptic receptors 5-HT1B, 5-HT1A, 5HT1D is to be blocked within a therapeutic context without greatly influencing other receptors.